NCT01369797

Brief Summary

Background : The evolving concept of frailty was born in the United States under the term of " frail elderly ". It allows describing geriatrics situations, dominated by the weakness or the functional instability of aged person, illustrating situations at risk. It is about an effective concept, especially in the field of the prevention where it determines strategies of specific care. The ageing, changing according to individuals, is characterized by a decrease of the physiological reserves leading to a precarious balance and to a destabilization. Epidemiological studies show a very uneven distribution of three categories of old persons according to their health status. Every year, approximately, 12 % of the independent population of 75 years of age and older and living at home, lose their autonomy for one of the activities of the daily life and turn into frailty. Identifying frailty of old subjects is interesting in order to apply preventive and specific care strategies to reduce the risks of decompensation. The Global Geriatric Assessment (GGA) is the gold standard to detect frailty in this population. The beneficial effects of the GGA during the hospitalization have been recognized in international literature. The ageing heterogeneousness complexity and the high time-consuming character of GGA led to a difficult approach for the nurses or family practioners in taking care of old persons at home. To balance these difficulties and to optimize prevention of dependence in the elderly, an experimental unit of prevention was created : Unit for Prevention, Monitoring and Analysis of Aging (UPSAV) on January 4th, 2010 within the geriatric department of the Hospital University of Limoges. It is an innovative organizational structure because, for the first time, the geriatric expertise is proposed freely to the elderly at home. A multidisciplinary gerontological team consisting in a geriatrician, a nurse, a psychomotor therapist and an occupational therapist, can, on requiry, move at old persons' home to make a preventive GGA to detect the risks of loss of autonomy and to propose a coordination of preventive actions. Purpose : UPSAV's endpoints are to prevent frail elderly persons from the risk of autonomy loss. This action is led in partnership with all the professionals working around old persons. The randomized study endpoint is to evaluate elderly from 75 years of age and older at home and to select two homogeneous groups: "reference" and " specific intervention ".

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
440

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2011

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

May 16, 2011

Completed
24 days until next milestone

First Posted

Study publicly available on registry

June 9, 2011

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
Last Updated

February 24, 2016

Status Verified

February 1, 2016

Enrollment Period

3.8 years

First QC Date

May 16, 2011

Last Update Submit

February 23, 2016

Conditions

Keywords

UPSAVautonomythe elderly of 75 years and older

Outcome Measures

Primary Outcomes (1)

  • Increase of 5 points of the score(function status) SMAF in 2 years

    To evaluate at 2 years the impact of the preventive and coordination action of the UPSAV's gerontological expertise by means of a questionnaire of quality of life.

    2 years

Secondary Outcomes (1)

  • Evaluation of the mortality in 2 years

    2 years

Study Arms (2)

reference

NO INTERVENTION

"reference" group, where every patient will benefit: of the same GGA at home as those of the " specific intervention " group. The GGA results will not be supplied to the family practioner.

specific intervention

EXPERIMENTAL

"specific intervention" group, where every patient will benefit: of an GGA at home. According to the frailties or the detected morbidity, a specific plan of intervention will be established for the person. all the preventive actions will be coordinated by UPSAV.

Other: specific intervention

Interventions

Patients included in the "specific intervention" group will benefit from a personalized action plan presented in a multidisciplinary staff that will be established according to the detected frailties. In follow up visits, a new evaluation will be done and the action plan reviewed.

specific intervention

Eligibility Criteria

Age75 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • years of age and older man or woman
  • Patient covered by the health care system
  • Patient coverd by a complementary health system or supported by 100% by the health care system
  • Patient having the intellectual skills to understand the study, to respect its imperatives and accept the UPSAV's plan or subject with mild to moderate dementia (MMSE \> 10) but with a caregiver at home capable of understanding the protocol and of making respect its imperatives written consent signed by the patient

You may not qualify if:

  • Nursing-home resident
  • Mild to moderate dementia (MMSE \> 10) without caregiver
  • Severe dementia (MMSE \< 10)
  • Diseases with vital short-term endpoint

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pôle Personnes âgées et soins à domicile - Limoges UH

Limoges, Limoges, 87042, France

Location

Study Officials

  • Thierry DANTOINE

    Limoges UH

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 16, 2011

First Posted

June 9, 2011

Study Start

May 1, 2011

Primary Completion

February 1, 2015

Study Completion

February 1, 2015

Last Updated

February 24, 2016

Record last verified: 2016-02

Locations